Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Plasmablastic lymphoma
ADR ID BADD_A08784
ADR Hierarchy
01      Blood and lymphatic system disorders
01.17      Lymphomas non-Hodgkin's unspecified histology
01.17.01      Non-Hodgkin's lymphomas NEC
01.17.01.004      Plasmablastic lymphoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.35      Lymphomas non-Hodgkin's unspecified histology
16.35.01      Non-Hodgkin's lymphomas NEC
16.35.01.004      Plasmablastic lymphoma
Description Malignant lymphoma composed of large B lymphoid cells which have the immunophenotype of plasma cells and a predilection for the ORAL CAVITY. [MeSH]
MedDRA Code 10065039
MeSH ID D000069293
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Plasmablastic lymphoma | Plasmablastic Lymphoma | Lymphoma, Plasmablastic | Lymphomas, Plasmablastic | Plasmablastic Lymphomas | Plasmablasts Diffuse Large B-cell Lymphoma | Plasmablasts Diffuse Large B cell Lymphoma | Plasmablastic Diffuse Large B-cell Lymphoma | Plasmablastic Diffuse Large B cell Lymphoma
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00195Azathioprine0.000562%
BADD_D01253Lenalidomide0.000453%
BADD_D01418Methotrexate0.000146%
The 1th Page    1    Total 1 Pages